Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors

Patent 10131667 was granted and assigned to Incyte on November, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Date of Patent

November 20, 2018

Patent Application Number

15408768

Date Filed

January 18, 2017

Patent Citations Received

US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11472801 Crystalline forms of a FGFR inhibitor and processes for preparing the same

US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent

0

US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors

0

US Patent 11466004 Solid forms of an FGFR inhibitor and processes for preparing the same

US Patent 10450313 Bicyclic heterocycles as FGFR inhibitors

US Patent 11530214 Bicyclic heterocycles as FGFR inhibitors

US Patent 10611762 Crystalline forms of a FGFR inhibitor and processes for preparing the same

...

Patent Primary Examiner

Patent abstract

The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10131667 Substituted tricyclic compounds as FGFR inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool